Activity

Filter

Cancel
Date Panel Item Activity
7 actions
Genomic newborn screening: BabyScreen+ v0.1919 CD3G Zornitza Stark Marked gene: CD3G as ready
Genomic newborn screening: BabyScreen+ v0.1919 CD3G Zornitza Stark Gene: cd3g has been classified as Green List (High Evidence).
Genomic newborn screening: BabyScreen+ v0.1919 CD3G Zornitza Stark Classified gene: CD3G as Green List (high evidence)
Genomic newborn screening: BabyScreen+ v0.1919 CD3G Zornitza Stark Gene: cd3g has been classified as Green List (High Evidence).
Genomic newborn screening: BabyScreen+ v0.1918 CD3G Zornitza Stark edited their review of gene: CD3G: Changed rating: GREEN
Genomic newborn screening: BabyScreen+ v0.1918 CD3G Zornitza Stark Tag treatable tag was added to gene: CD3G.
Tag immunological tag was added to gene: CD3G.
Genomic newborn screening: BabyScreen+ v0.1918 CD3G Zornitza Stark gene: CD3G was added
gene: CD3G was added to gNBS. Sources: Expert list
Mode of inheritance for gene: CD3G was set to BIALLELIC, autosomal or pseudoautosomal
Publications for gene: CD3G were set to 31921117
Phenotypes for gene: CD3G were set to Immunodeficiency 17; CD3 gamma deficient MIM# 615607
Added comment: 10 affected individuals from 5 unrelated families; homozygous and compound heterozygous variants (splicing, missense and small deletion variants) identified resulting in premature stop codons and truncated protein; multiple mouse models.

All individuals displayed immune deficiency and autoimmunity of variable severity. Some individuals presented at birth with failure to thrive due to lethal SCID features. The most common immunologic profile includes partial T lymphocytopenia and low CD3, with normal B cells, NK cells, and immunoglobulins.

Congenital onset.

Treatment: replacement immunoglobulin

Non-genetic confirmatory testing: immunoglobulin levels
Sources: Expert list